AAAAAA

   
Results: 1-9 |
Results: 9
Sentinel lymph node detection for breast cancer: Which patients are best suited for the patent blue dye only method of identification?
Authors: Nos, C Freneaux, P Guilbert, S Falcou, MC Salmon, RJ Clough, KB
Citation: C. Nos et al., Sentinel lymph node detection for breast cancer: Which patients are best suited for the patent blue dye only method of identification?, ANN SURG O, 8(5), 2001, pp. 438-443
Improving the reliability of sentinel lymph node biopsy in breast cancer
Authors: Nos, C Freneaux, P Louis-Sylvestre, C Sastre-Garau, X Clough, KB
Citation: C. Nos et al., Improving the reliability of sentinel lymph node biopsy in breast cancer, PRESSE MED, 30(28), 2001, pp. 1394-1398
Long term outcome of small size invasive breast carcinomas independent from angiogenesis in a series of 685 cases
Authors: Vincent-Salomon, A Carton, M Zafrani, B Freneaux, P Nicolas, A Massemin, B Fourquet, A Clough, K Pouillart, P Sastre-Garau, X
Citation: A. Vincent-salomon et al., Long term outcome of small size invasive breast carcinomas independent from angiogenesis in a series of 685 cases, CANCER, 92(2), 2001, pp. 249-256
T-cell infiltrate after monoclonal anti-CD20 antibody therapy for B-cell lymphoma
Authors: Vincent-Salomon, A Mathiot, C MacIntyre, E Girre, V Fourquet, A Mercier, C Freneaux, P Dumont, J Decaudin, D
Citation: A. Vincent-salomon et al., T-cell infiltrate after monoclonal anti-CD20 antibody therapy for B-cell lymphoma, LEUK LYMPH, 37(3-4), 2000, pp. 387
ERBB2 overexpression in breast carcinomas: no positive correlation with complete pathological response to preoperative high-dose anthracycline-based chemotherapy
Authors: Vincent-Salomon, A Carton, M Freneaux, P Palangie, T Beuzeboc, P Mouret, E de Cremoux, P Coue, O Zafrani, B Nicolas, A Clough, K Fourquet, A Pouillart, P Sastre-Garau, X
Citation: A. Vincent-salomon et al., ERBB2 overexpression in breast carcinomas: no positive correlation with complete pathological response to preoperative high-dose anthracycline-based chemotherapy, EUR J CANC, 36(5), 2000, pp. 586-591
Interest of macroscopic analysis to authentify axillary sentinel nodes detected by Patent Blue dye alone in breast cancer surgery
Authors: Freneaux, P Nos, C Charvolin, JY Vincent-Salomon, A Zafrani, B Salmon, RJ Clough, KB Sastre-Garau, X
Citation: P. Freneaux et al., Interest of macroscopic analysis to authentify axillary sentinel nodes detected by Patent Blue dye alone in breast cancer surgery, ANN PATHOL, 20(6), 2000, pp. 545-548
The RB1 gene is the target of chromosome 13 deletions in malignant fibroushistiocytoma
Authors: Chibon, F Mairal, A Freneaux, P Terrier, P Coindre, JM Sastre, X Aurias, A
Citation: F. Chibon et al., The RB1 gene is the target of chromosome 13 deletions in malignant fibroushistiocytoma, CANCER RES, 60(22), 2000, pp. 6339-6345
Low expression of bcl-2 in Brca1-associated breast cancers
Authors: Freneaux, P Stoppa-Lyonnet, D Mouret, E Kambouchner, M Nicolas, A Zafrani, B Vincent-Salomon, A Fourquet, A Magdelenat, H Sastre-Garau, X
Citation: P. Freneaux et al., Low expression of bcl-2 in Brca1-associated breast cancers, BR J CANC, 83(10), 2000, pp. 1318-1322
Identification of sentinel lymph node in breast cancer: experience from the Institut Curie
Authors: Nos, C Bourgeois, D Freneaux, P Zafrani, B Salmon, RJ Clough, KB
Citation: C. Nos et al., Identification of sentinel lymph node in breast cancer: experience from the Institut Curie, B CANCER, 86(6), 1999, pp. 580-584
Risultati: 1-9 |